Your browser doesn't support javascript.
loading
An open-label, multicenter, randomized, phase II study of pazopanib in combination with pemetrexed in first-line treatment of patients with advanced-stage non-small-cell lung cancer.
Scagliotti, Giorgio V; Felip, Enriqueta; Besse, Benjamin; von Pawel, Joachim; Mellemgaard, Anders; Reck, Martin; Bosquee, Lionel; Chouaid, Christos; Lianes-Barragán, Pilar; Paul, Elaine M; Ruiz-Soto, Rodrigo; Sigal, Entisar; Ottesen, Lone H; Lechevalier, Thierry.
Afiliação
  • Scagliotti GV; *Department of Clinical and Biological Sciences, University of Turin, Orbassano, Torino, Italy; †Department of Oncology, Vall d'Hebron University Hospital, Barcelona, Spain; ‡Department of Cancer Medicine, Institut Gustave Roussy, Villejuif, France; §Asklepios Clinic, Asklepios Fachkliniken München-Gauting, Gauting, Germany; ‖Department of Oncology, Herlev Hospital, Onkologisk afdeling, Herlev, Denmark; ¶Department of Thoracic Oncology, Hospital Grosshansdorf, Grosshansdorf, Germany; #Department
J Thorac Oncol ; 8(12): 1529-37, 2013 Dec.
Article em En | MEDLINE | ID: mdl-24389434

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Adenocarcinoma / Protocolos de Quimioterapia Combinada Antineoplásica / Carcinoma de Células Grandes / Carcinoma Pulmonar de Células não Pequenas / Adenocarcinoma Bronquioloalveolar / Neoplasias Pulmonares Idioma: En Ano de publicação: 2013 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Adenocarcinoma / Protocolos de Quimioterapia Combinada Antineoplásica / Carcinoma de Células Grandes / Carcinoma Pulmonar de Células não Pequenas / Adenocarcinoma Bronquioloalveolar / Neoplasias Pulmonares Idioma: En Ano de publicação: 2013 Tipo de documento: Article